Get started
Author

Lu Wei

Observed names: LU WEI, Wei Lu
ORCID: 0009-0006-2987-9444
Observed ORCID: 0009-0006-2987-9444
OpenAlex ID: A5101239112
Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral Therapy
2024 · Hang Wang, Bobin Hu, et al. · International Journal of General Medicine · 7
PDF
Correlation Between Serum ESPL1 and Hepatitis B Virus-related Hepatocellular Carcinoma Histological Grade: A Chinese Single-center Case-control Study
2023 · BOBIN HU, LU WEI, et al. · Anticancer Research · 5
Tibial periosteal distraction for ischemic leg ulcers: animal and clinical cohort study
2025 · Peilin Zhou, Wenqiang Wang, et al. · BMC Medicine · 3
Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma
2025 · Lu-Huai Feng, Lu Wei, et al. · Frontiers in Oncology · 3
PDF
Serum ESPL1 Protein as an Early Warning Biomarker for the Initial Occurrence and Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma
2023 · Bobin Hu, Deli Deng, et al. · Research Square · 1
PDF
Artificial Intelligence-Empowered "Walking Hospitals”: A Narrative Review of Innovative Models and Ecosystem Construction in Rural Healthcare
2026 · Wei Lu, Gang Feng, et al. · International Journal of General Medicine
PDF
Tumor-Restricted CXCR4 and MIF Signaling Axis is Associated with T Cell-Mediated Macrophage Exclusion in Gastrointestinal Stromal Tumors
2026 · Fulai Gao, Wei Lu, et al. · International Journal of General Medicine
PDF
Development and Validation of an Extra Spindle Pole Bodies–like 1–Based Diagnostic and Prognostic Model for Hepatitis B Virus–Related Hepatocellular Carcinoma: Retrospective Cohort Study
2025 · Lu-Huai Feng, Hengkai Liang, et al. · JMIR Medical Informatics
PDF
Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis.
2025 · Yan-Fei Feng, Hui-Kun Zhou, et al. · PubMed Central
PDF
Works count: 9
Citation count: 19
H-index: 3
I10-index:
Year
Topic
Type